OpenURL Connection Search

Select item for more details and to access through your institution.

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.
Published in:
Journal of Hematology & Oncology, 2020, v. 13, n. 1, p. 1, doi. 10.1186/s13045-020-0846-y
By:
- Coussy, F.;
- El Botty, R.;
- Lavigne, M.;
- Gu, C.;
- Fuhrmann, L.;
- Briaux, A.;
- de Koning, L.;
- Dahmani, A.;
- Montaudon, E.;
- Morisset, L.;
- Huguet, L.;
- Sourd, L.;
- Painsec, P.;
- Chateau-Joubert, S.;
- Larcher, T.;
- Vacher, S.;
- Melaabi, S.;
- Salomon, A. Vincent;
- Marangoni, E.;
- Bieche, I.
Publication type:
Article
Clinical value of R-spondins in triple-negative and metaplastic breast cancers.
Published in:
2017
By:
- Coussy, F;
- Lallemand, F;
- Vacher, S;
- Schnitzler, A;
- Chemlali, W;
- Caly, M;
- Nicolas, A;
- Richon, S;
- Meseure, D;
- El Botty, R;
- De-Plater, L;
- Fuhrmann, L;
- Dubois, T;
- Roman-Roman, S;
- Dangles-Marie, V;
- Marangoni, E;
- Bièche, I;
- Bièche, I
Publication type:
journal article
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.
Published in:
British Journal of Cancer, 2014, v. 110, n. 6, p. 1413, doi. 10.1038/bjc.2014.81
By:
- Giacchetti, S;
- Porcher, R;
- Lehmann-Che, J;
- Hamy, A-S;
- de Roquancourt, A;
- Cuvier, C;
- Cottu, P-H;
- Bertheau, P;
- Albiter, M;
- Bouhidel, F;
- Coussy, F;
- Extra, J-M;
- Marty, M;
- de Thé, H;
- Espié, M
Publication type:
Article
HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.
Published in:
British Journal of Cancer, 2013, v. 109, n. 5, p. 1157, doi. 10.1038/bjc.2013.469
By:
- Groheux, D;
- Giacchetti, S;
- Hatt, M;
- Marty, M;
- Vercellino, L;
- de Roquancourt, A;
- Cuvier, C;
- Coussy, F;
- Espié, M;
- Hindié, E
Publication type:
Article

Found: 4

Combination of PI3K and MEK inhibitors yields durable remission in PDX models of PIK3CA-mutated metaplastic breast cancers.

Clinical value of R-spondins in triple-negative and metaplastic breast cancers.

Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimen.

HER2-overexpressing breast cancer: FDG uptake after two cycles of chemotherapy predicts the outcome of neoadjuvant treatment.